148 related articles for article (PubMed ID: 37718465)
41. Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts.
Pintea B; Baumert B; Kinfe TM; Gousias K; Parpaley Y; Boström JP
Radiat Oncol; 2017 Nov; 12(1):177. PubMed ID: 29132382
[TBL] [Abstract][Full Text] [Related]
42. A novel dose fall-off index and preliminary application in brain and lung stereotactic radiotherapy.
Shen Z; Luo H; Li S; Tan X; Tian X; Liu Q; Jin F
Med Phys; 2023 May; 50(5):3127-3136. PubMed ID: 36960718
[TBL] [Abstract][Full Text] [Related]
43. Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.
Miyakawa A; Shibamoto Y; Takemoto S; Serizawa T; Otsuka S; Hirai T
Int J Clin Oncol; 2017 Apr; 22(2):250-256. PubMed ID: 27826659
[TBL] [Abstract][Full Text] [Related]
44. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
45. Gamma knife radiosurgery for brain metastases: do patients benefit from adjuvant external-beam radiotherapy? An 18-month comparative analysis.
Jawahar A; Willis BK; Smith DR; Ampil F; Datta R; Nanda A
Stereotact Funct Neurosurg; 2002; 79(3-4):262-71. PubMed ID: 12890985
[TBL] [Abstract][Full Text] [Related]
46. MRI appearance change during stereotactic radiotherapy for large brain metastases and importance of treatment plan modification during treatment period.
Kubo K; Kenjo M; Doi Y; Nakao M; Miura H; Ozawa S; Nagata Y
Jpn J Radiol; 2019 Dec; 37(12):850-859. PubMed ID: 31617151
[TBL] [Abstract][Full Text] [Related]
47. Magnetic resonance imaging evaluation of treatment efficacy and prognosis for brain metastases in lung cancer patients after radiotherapy: A preliminary study.
Liu Y; Liu X; Xu L; Liu L; Sun Y; Li M; Zeng H; Yuan S; Yu J
Thorac Cancer; 2018 Jul; 9(7):865-873. PubMed ID: 29774659
[TBL] [Abstract][Full Text] [Related]
48. [Therapeutic effect of gamma-ray stereotactic radiotherapy on brain metastases].
Wei R; Ma ZM; Yuan J
Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):451-2. PubMed ID: 12536499
[TBL] [Abstract][Full Text] [Related]
49. Quantitative MRI study of the permeability of peritumoral brain edema in lung cancer patients with brain metastases.
Wang D; Wang ML; Li YH
Brain Res; 2017 Aug; 1669():126-130. PubMed ID: 28633995
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant.
Zhao L; Cai X; Chen D; Ye X; Gao M; Lu L; Su H; Su M; Hou M; Xie C
Radiat Oncol; 2019 Dec; 15(1):3. PubMed ID: 31892337
[TBL] [Abstract][Full Text] [Related]
51. Influence of interleukin-6 on the development of peritumoral brain edema in meningiomas.
Park KJ; Kang SH; Chae YS; Yu MO; Cho TH; Suh JK; Lee HK; Chung YG
J Neurosurg; 2010 Jan; 112(1):73-80. PubMed ID: 19445568
[TBL] [Abstract][Full Text] [Related]
52. Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series.
Fessart E; Mouttet Audouard R; Le Tinier F; Coche-Dequeant B; Lacornerie T; Tresch E; Scherpereel A; Lartigau E; Mirabel X; Pasquier D
Sci Rep; 2020 Jul; 10(1):11201. PubMed ID: 32641798
[TBL] [Abstract][Full Text] [Related]
53. The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review.
Lancellotta V; Del Regno L; Di Stefani A; Fionda B; Marazzi F; Rossi E; Balducci M; Pampena R; Morganti AG; Mangoni M; Lebbe C; Garbe C; Longo C; Schinzari G; Tagliaferri L; Peris K
Radiol Med; 2022 Jul; 127(7):773-783. PubMed ID: 35606609
[TBL] [Abstract][Full Text] [Related]
54. Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases.
Guénolé M; Lucia F; Bourbonne V; Dissaux G; Reygagne E; Goasduff G; Pradier O; Schick U
BMC Cancer; 2020 Oct; 20(1):991. PubMed ID: 33050910
[TBL] [Abstract][Full Text] [Related]
55. Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma.
Kickingereder P; Wiestler B; Burth S; Wick A; Nowosielski M; Heiland S; Schlemmer HP; Wick W; Bendszus M; Radbruch A
Neuro Oncol; 2015 Aug; 17(8):1139-47. PubMed ID: 25754089
[TBL] [Abstract][Full Text] [Related]
56. Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis.
Calderon B; Vazquez L; Belkacemi M; Pourel N
Eur J Med Res; 2023 Jul; 28(1):233. PubMed ID: 37443046
[TBL] [Abstract][Full Text] [Related]
57. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
[TBL] [Abstract][Full Text] [Related]
58. Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases.
Lucia F; Key S; Dissaux G; Goasduff G; Lucia AS; Ollivier L; Pradier O; Schick U
Radiother Oncol; 2019 Jan; 130():132-138. PubMed ID: 30017105
[TBL] [Abstract][Full Text] [Related]
59. Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis.
Pishko GL; Muldoon LL; Pagel MA; Schwartz DL; Neuwelt EA
Fluids Barriers CNS; 2015 Feb; 12():5. PubMed ID: 25879723
[TBL] [Abstract][Full Text] [Related]
60. Radiosurgery for brain metastases and cerebral edema.
Gazit I; Har-Nof S; Cohen ZR; Zibly Z; Nissim U; Spiegelmann R
J Clin Neurosci; 2015 Mar; 22(3):535-8. PubMed ID: 25533053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
